UniProt ID | RBM12_HUMAN | |
---|---|---|
UniProt AC | Q9NTZ6 | |
Protein Name | RNA-binding protein 12 | |
Gene Name | RBM12 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 932 | |
Subcellular Localization | Nucleus . | |
Protein Description | ||
Protein Sequence | MAVVIRLQGLPIVAGTMDIRHFFSGLTIPDGGVHIVGGELGEAFIVFATDEDARLGMMRTGGTIKGSKVTLLLSSKTEMQNMIELSRRRFETANLDIPPANASRSGPPPSSGMSSRVNLPTTVSNFNNPSPSVVTATTSVHESNKNIQTFSTASVGTAPPNMGASFGSPTFSSTVPSTASPMNTVPPPPIPPIPAMPSLPPMPSIPPIPVPPPVPTLPPVPPVPPIPPVPSVPPMTPLPPMSGMPPLNPPPVAPLPAGMNGSGAPMNLNNNLNPMFLGPLNPVNPIQMNSQSSVKPLPINPDDLYVSVHGMPFSAMENDVRDFFHGLRVDAVHLLKDHVGRNNGNGLVKFLSPQDTFEALKRNRMLMIQRYVEVSPATERQWVAAGGHITFKQNMGPSGQTHPPPQTLPRSKSPSGQKRSRSRSPHEAGFCVYLKGLPFEAENKHVIDFFKKLDIVEDSIYIAYGPNGKATGEGFVEFRNEADYKAALCRHKQYMGNRFIQVHPITKKGMLEKIDMIRKRLQNFSYDQREMILNPEGDVNSAKVCAHITNIPFSITKMDVLQFLEGIPVDENAVHVLVDNNGQGLGQALVQFKNEDDARKSERLHRKKLNGREAFVHVVTLEDMREIEKNPPAQGKKGLKMPVPGNPAVPGMPNAGLPGVGLPSAGLPGAGLPSTGLPGSAITSAGLPGAGMPSAGIPSAGGEEHAFLTVGSKEANNGPPFNFPGNFGGSNAFGPPIPPPGLGGGAFGDARPGMPSVGNSGLPGLGLDVPGFGGGPNNLSGPSGFGGGPQNFGNGPGSLGGPPGFGSGPPGLGSAPGHLGGPPAFGPGPGPGPGPGPIHIGGPPGFASSSGKPGPTVIKVQNMPFTVSIDEILDFFYGYQVIPGSVCLKYNEKGMPTGEAMVAFESRDEATAAVIDLNDRPIGSRKVKLVLG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
16 | Phosphorylation | GLPIVAGTMDIRHFF CCCEEEEEEEHHHHH | 11.26 | - | |
17 | Sulfoxidation | LPIVAGTMDIRHFFS CCEEEEEEEHHHHHC | 3.84 | 21406390 | |
67 | Phosphorylation | TGGTIKGSKVTLLLS CCCEECCCEEEEEEC | 20.96 | - | |
67 | O-linked_Glycosylation | TGGTIKGSKVTLLLS CCCEECCCEEEEEEC | 20.96 | 30059200 | |
70 | Phosphorylation | TIKGSKVTLLLSSKT EECCCEEEEEECCCH | 18.54 | - | |
77 | Phosphorylation | TLLLSSKTEMQNMIE EEEECCCHHHHHHHH | 38.34 | - | |
111 | Phosphorylation | RSGPPPSSGMSSRVN CCCCCCCCCCCCCCC | 44.27 | - | |
111 | O-linked_Glycosylation | RSGPPPSSGMSSRVN CCCCCCCCCCCCCCC | 44.27 | 30059200 | |
121 | O-linked_Glycosylation | SSRVNLPTTVSNFNN CCCCCCCCCHHCCCC | 42.89 | 30059200 | |
122 | O-linked_Glycosylation | SRVNLPTTVSNFNNP CCCCCCCCHHCCCCC | 21.72 | 30059200 | |
124 | O-linked_Glycosylation | VNLPTTVSNFNNPSP CCCCCCHHCCCCCCC | 33.34 | 30059200 | |
130 | Phosphorylation | VSNFNNPSPSVVTAT HHCCCCCCCCCEEEE | 31.75 | 27050516 | |
130 | O-linked_Glycosylation | VSNFNNPSPSVVTAT HHCCCCCCCCCEEEE | 31.75 | 30059200 | |
132 | O-linked_Glycosylation | NFNNPSPSVVTATTS CCCCCCCCCEEEEEE | 33.29 | 30059200 | |
135 | O-linked_Glycosylation | NPSPSVVTATTSVHE CCCCCCEEEEEEEEC | 19.01 | 30059200 | |
137 | O-linked_Glycosylation | SPSVVTATTSVHESN CCCCEEEEEEEECCC | 15.39 | 30059200 | |
138 | O-linked_Glycosylation | PSVVTATTSVHESNK CCCEEEEEEEECCCC | 26.70 | 30059200 | |
139 | O-linked_Glycosylation | SVVTATTSVHESNKN CCEEEEEEEECCCCC | 19.68 | 30059200 | |
143 | O-linked_Glycosylation | ATTSVHESNKNIQTF EEEEEECCCCCCEEE | 37.92 | 30059200 | |
149 | O-linked_Glycosylation | ESNKNIQTFSTASVG CCCCCCEEEEECCCC | 18.76 | 30059200 | |
295 | Sumoylation | MNSQSSVKPLPINPD CCCCCCCCCCCCCHH | 42.67 | - | |
336 | 2-Hydroxyisobutyrylation | VDAVHLLKDHVGRNN HHHHHHHHHHCCCCC | 52.74 | - | |
336 | Ubiquitination | VDAVHLLKDHVGRNN HHHHHHHHHHCCCCC | 52.74 | 33845483 | |
349 | Ubiquitination | NNGNGLVKFLSPQDT CCCCCCEEECCHHHH | 45.70 | 21890473 | |
352 | Phosphorylation | NGLVKFLSPQDTFEA CCCEEECCHHHHHHH | 24.53 | 25159151 | |
356 | Phosphorylation | KFLSPQDTFEALKRN EECCHHHHHHHHHHC | 20.37 | 20068231 | |
361 | Ubiquitination | QDTFEALKRNRMLMI HHHHHHHHHCCEEEE | 55.46 | 32142685 | |
361 | Acetylation | QDTFEALKRNRMLMI HHHHHHHHHCCEEEE | 55.46 | 24846347 | |
371 | Phosphorylation | RMLMIQRYVEVSPAT CEEEEEEEEECCCCC | 5.65 | 28152594 | |
375 | Phosphorylation | IQRYVEVSPATERQW EEEEEECCCCCCCEE | 8.70 | 29255136 | |
378 | Phosphorylation | YVEVSPATERQWVAA EEECCCCCCCEEEEE | 34.78 | 29255136 | |
395 | Sulfoxidation | HITFKQNMGPSGQTH EEEEECCCCCCCCCC | 8.49 | 21406390 | |
398 | Phosphorylation | FKQNMGPSGQTHPPP EECCCCCCCCCCCCC | 37.49 | 26074081 | |
401 | Phosphorylation | NMGPSGQTHPPPQTL CCCCCCCCCCCCCCC | 39.62 | 26074081 | |
407 | Phosphorylation | QTHPPPQTLPRSKSP CCCCCCCCCCCCCCC | 44.49 | 26074081 | |
411 | Phosphorylation | PPQTLPRSKSPSGQK CCCCCCCCCCCCCCC | 35.23 | 26699800 | |
413 | Phosphorylation | QTLPRSKSPSGQKRS CCCCCCCCCCCCCCC | 26.08 | 27422710 | |
415 | Phosphorylation | LPRSKSPSGQKRSRS CCCCCCCCCCCCCCC | 62.03 | 28176443 | |
420 | Phosphorylation | SPSGQKRSRSRSPHE CCCCCCCCCCCCHHC | 41.46 | 23401153 | |
422 | Phosphorylation | SGQKRSRSRSPHEAG CCCCCCCCCCHHCCC | 38.05 | 22167270 | |
424 | Phosphorylation | QKRSRSRSPHEAGFC CCCCCCCCHHCCCEE | 31.67 | 22167270 | |
433 | Phosphorylation | HEAGFCVYLKGLPFE HCCCEEEEECCCCCC | 12.13 | 20164059 | |
444 | Ubiquitination | LPFEAENKHVIDFFK CCCCCCCHHHHHHHH | 30.65 | 23000965 | |
444 | Acetylation | LPFEAENKHVIDFFK CCCCCCCHHHHHHHH | 30.65 | 27452117 | |
444 | 2-Hydroxyisobutyrylation | LPFEAENKHVIDFFK CCCCCCCHHHHHHHH | 30.65 | - | |
451 | Ubiquitination | KHVIDFFKKLDIVED HHHHHHHHHCCCCCC | 53.04 | 33845483 | |
451 | Acetylation | KHVIDFFKKLDIVED HHHHHHHHHCCCCCC | 53.04 | 19608861 | |
485 | Ubiquitination | FRNEADYKAALCRHK ECCHHHHHHHHHHCH | 27.94 | 33845483 | |
485 | Acetylation | FRNEADYKAALCRHK ECCHHHHHHHHHHCH | 27.94 | 23749302 | |
485 | Methylation | FRNEADYKAALCRHK ECCHHHHHHHHHHCH | 27.94 | 82987705 | |
485 | 2-Hydroxyisobutyrylation | FRNEADYKAALCRHK ECCHHHHHHHHHHCH | 27.94 | - | |
506 | Phosphorylation | FIQVHPITKKGMLEK EEEEEECCCCCHHHH | 31.02 | 29209046 | |
507 | Ubiquitination | IQVHPITKKGMLEKI EEEEECCCCCHHHHH | 48.31 | 29967540 | |
513 | Acetylation | TKKGMLEKIDMIRKR CCCCHHHHHHHHHHH | 39.79 | 26822725 | |
525 | Phosphorylation | RKRLQNFSYDQREMI HHHHHCCCCCCCCCC | 35.04 | 28796482 | |
526 | Phosphorylation | KRLQNFSYDQREMIL HHHHCCCCCCCCCCC | 16.38 | 26462736 | |
531 | Sulfoxidation | FSYDQREMILNPEGD CCCCCCCCCCCCCCC | 4.62 | 21406390 | |
554 | Phosphorylation | HITNIPFSITKMDVL HHHCCCCCEEHHHHH | 24.80 | 25627689 | |
593 | Sumoylation | GQALVQFKNEDDARK HHHHHEECCHHHHHH | 42.19 | - | |
629 | Ubiquitination | EDMREIEKNPPAQGK HHHHHHHHCCCCCCC | 79.15 | 29967540 | |
636 | Acetylation | KNPPAQGKKGLKMPV HCCCCCCCCCCCCCC | 31.43 | 25953088 | |
893 | Ubiquitination | VCLKYNEKGMPTGEA EEEEECCCCCCCCEE | 57.80 | - | |
893 | Acetylation | VCLKYNEKGMPTGEA EEEEECCCCCCCCEE | 57.80 | 25953088 | |
897 | Phosphorylation | YNEKGMPTGEAMVAF ECCCCCCCCEEEEEE | 38.47 | 26552605 | |
906 | Phosphorylation | EAMVAFESRDEATAA EEEEEEECCCCCCEE | 38.28 | 26552605 | |
920 | Methylation | AVIDLNDRPIGSRKV EEEECCCCCCCCCEE | 24.54 | 115490499 | |
924 | Phosphorylation | LNDRPIGSRKVKLVL CCCCCCCCCEEEEEC | 29.64 | 28555341 | |
925 | Methylation | NDRPIGSRKVKLVLG CCCCCCCCEEEEECC | 42.44 | 115490507 | |
926 | Methylation | DRPIGSRKVKLVLG- CCCCCCCEEEEECC- | 45.48 | 115490515 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RBM12_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RBM12_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RBM12_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SDHF2_HUMAN | SDHAF2 | physical | 22939629 | |
BIN1_HUMAN | BIN1 | physical | 22863883 | |
GMPPB_HUMAN | GMPPB | physical | 22863883 | |
GLCNE_HUMAN | GNE | physical | 22863883 | |
RBGPR_HUMAN | RAB3GAP2 | physical | 22863883 | |
UBE4B_HUMAN | UBE4B | physical | 22863883 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-420; SER-422 ANDSER-424, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-424, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-415; SER-420; SER-422AND SER-424, AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-420; SER-422 ANDSER-424, AND MASS SPECTROMETRY. | |
"Robust phosphoproteomic profiling of tyrosine phosphorylation sitesfrom human T cells using immobilized metal affinity chromatography andtandem mass spectrometry."; Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,Peters E.C.; Anal. Chem. 76:2763-2772(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-526, AND MASSSPECTROMETRY. |